FDA data Registry peer set 4 peers FDA shortage listed

Alternatives to ceftazidime

FDA shortage status is active for ceftazidime; 4 same-class SPL records are listed below for registry comparison only.

Brand: Fortaz

Third-Generation Cephalosporin Prescription 4 alternatives found

ceftazidime class peers while FDA lists an active shortage

ceftazidime (Fortaz) is on an FDA shortage listing while 4 other Third-Generation Cephalosporin SPL records remain in this registry peer set (class inventory 5). Labeled indication field for ceftazidime: Ceftazidime treats many kinds of infections caused by bacteria.

Top FAERS reaction fields for ceftazidime total 3,178 reports across 10 reactions, set beside cefdinir, cefixime, cefpodoxime. Counts are exposure-weighted submissions, not per-patient risk.

About ceftazidime

Ceftazidime is an antibiotic medicine. It fights bacterial infections in your body.

Used for: Ceftazidime treats many kinds of infections caused by bacteria. This includes lung infections like pneumonia, skin infections, and urinary tract infections. It can also treat blood infections, bone and joint infections, and infections in the abdomen, the female reproductive system, and the brain (like meningitis).

4 Third-Generation Cephalosporin peers (wide set)

Compare ceftazidime vs cefdinir side-by-side →

ceftazidime vs cefdinir & cefixime · FAERS reaction fields

FAERS top-reaction field "Septic Shock" shows the widest count spread between ceftazidime and cefdinir, cefixime, cefpodoxime in this extract (334-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect ceftazidime cefdinircefiximecefpodoxime
Pyrexia 533 279 162 -
Septic Shock 334 - - -
Condition Aggravated 319 - 110 -
Neutropenia 317 - - -
Pneumonia 294 466 84 -
Acute Kidney Injury 293 324 - -
Diarrhoea 293 508 150 -
Febrile Neutropenia 268 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

ceftazidime shortage vs Third-Generation Cephalosporin peer index

Shortage status

FDA shortage listing is active for ceftazidime (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for ceftazidime while peers remain indexed?
Yes - ceftazidime matched an active FDA shortage listing (To Be Discontinued) while 4 other Third-Generation Cephalosporin SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full ceftazidime profile →

Field note for ceftazidime: see also the generic vs brand label guide when reading Fortaz SPL strings.